FIRST-IN-HUMAN PHASE 1/2A STUDY OF THE NOVEL NONFUCOSYLATED ANTI-CTLA-4 MONOCLONAL ANTIBODY BMS-986218 +/- NIVOLUMAB IN ADVANCED SOLID TUMORS: INITIAL PHASE 1 RESULTS-MedSci.cn

FIRST-IN-HUMAN PHASE 1/2A STUDY OF THE NOVEL NONFUCOSYLATED ANTI-CTLA-4 MONOCLONAL ANTIBODY BMS-986218 +/- NIVOLUMAB IN ADVANCED SOLID TUMORS: INITIAL PHASE 1 RESULTS

Friedman, C; Ascierto, P; Davar, D; O'Hara, M; Shapira-Frommer, R; Dallos, M; Khemka, V; James, L; Fischer, B; Demes, S; Li, L; Kozicki, M; Ravindran, P; Xu, K; Kollia, G; Shoukry, J; Yunan, M; Massey, A; Gutierrez, M

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A239

科室
- - 订阅+
  - 更多科室
工具
服务